Opinion: Who benefits from classifying obesity as a disease?
From the article
“The new wave of obesity pharmacotherapy has leaned heavily on disease framing,” writes Max Moser, drawing comparisons to the antidepressant revolution.
Continue reading on STATYou might also wanna read
Medicine can treat obesity, but can’t agree on what obesity is
The Economist·2d ago
expert reaction to review of obesity drugs and quality of life / heart health
Science Media Centre·11h ago
Study: Obesity Accounts for 1 in 7 Polypharmacy Cases Among Older US Adults
A cross-sectional analysis of a US cohort found that obesity significantly contributes to polypharmacy among older adults. BMI-defined obesi
mdsc.pe·2d ago
Experts share the latest updates on the Standards of Care in Overweight and Obesity
adameetingnews.org·14d ago
Five Trends That Will Shape the Future of Obesity Care in India: Ajanta Pharma Shares Its Perspective on the Next Decade of Metabolic Health
bignewsnetwork.com·3h ago
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
clinicaltrials.gov·3d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.